13F Holdings
中文EN

SMNR Semnur Pharmaceuticals, Inc.

Pharmaceutical Preparations · OTC · SEC CIK 1913577 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY87.9%
TTM EPS YoY90.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-1,344.9%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets1,757.8%
Debt / equity—
Current ratio0.11x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.57x
Accruals ratio-580.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31
Income statement
Revenue————
R&D expense$2.55M$1.71M——
SG&A expense$157.87M$2.98M——
Operating income-$160.42M-$4.69M-$3.17M—
Interest expense—$96,242$36,909—
Pretax income$0$0——
Income tax$0$0——
Net income-$160.42M-$4.69M$632,536-$419,390
EBITDA-$160.42M-$4.69M——
EPS (basic)-0.78-0.02——
EPS (diluted)-0.78-0.02——
Weighted avg. shares (diluted)204.78M200.00M——
Banking
Deposits—$75,292——
Balance sheet
Cash & equivalents$20,000$12,000$12,000$819,747
Current assets$596,000$6.00M$209,440$907,836
PP&E, net$750,000$689,000——
Total assets$1.35M$6.68M$50.69M$86.28M
Current liabilities$10.17M$35,000$5.60M$1.29M
Total liabilities$22.10M$49.47M$8.49M$4.18M
Shareholders' equity-$20.75M-$42.78M-$38.09M-$3.27M
Shares outstanding230.21M200.00M——
Cash flow statement
Operating cash flow-$5.87M-$4.89M-$632,783-$426,095
Investing cash flow—$43.43M$39.71M-$84.15M
Financing cash flow$5.88M$4.89M-$39.69M$85.40M
Depreciation & amortization$0$0——
Stock-based compensation$142.44M$660,000——
Share buybacks—$43.43M$40.54M—

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.